CTSB and lung carcinoma: The microtubule-destabilizing chemotherapeutic agent Vinblastine produced a response similar to that of BMPR2 inhibition with an increase in lysosome acidification, cytosol localization, and increase in Cathepsin B activity in lung cancer cells and MDA-MB-468 cells.